Back to Search Start Over

Tumor-induced osteomalacia treated with T12 tumor resection

Authors :
Alyssa J Mancini
Amin Sabet
Gunnlaugur Petur Nielsen
J Anthony Parker
Joseph H Schwab
Ashley Ward
Jim S Wu
Alan O Malabanan
Source :
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2022)
Publication Year :
2022
Publisher :
Bioscientifica, 2022.

Abstract

Tumor-induced osteomalacia (TIO) is a rare form of osteomalacia caused by fibroblast growth factor-23 (FGF23)- secreting tumors. Most of these tumors are phosphaturic mesenchymal tumors (PMTs) typically involving soft tissue in the extremities and bone of the appendicular skeleton and cranium. We report the case of a 60-year-old woman with about 3 years of persistent bone pain and multiple fractures, initially diagnosed as osteoporosis, who was found to have hypophosphatemia with low 1,25-dihydroxyvitamin D and elevated alkaline phosphatase and inappropriately normal FGF23 consistent with TIO. Her symptoms improved with phosphate supplementation, vitamin D and calcitriol. 68Ga-DOTATATE imaging revealed a T12 vertebral body lesion confirmed on biopsy to be a PMT. She underwent resection of the PMT with resolution of TIO and increased bone density. This rare case of TIO secondary to a PMT of the thoracic spine highlights some of the common features of PMT-associated TIO and draws attention to PMT-associated TIO as a possible cause of unexplained persistent bone pain, a disease entity that often goes undiagnosed and untreated for years.

Details

Language :
English
ISSN :
20520573
Volume :
1
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Endocrinology, Diabetes & Metabolism Case Reports
Publication Type :
Academic Journal
Accession number :
edsdoj.2926e003314604ae7217e38bb692af
Document Type :
article
Full Text :
https://doi.org/10.1530/EDM-22-0344